Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Curanex Pharmaceuticals(CURX) the EBIT is -3.326 M (-5668%);the EPS is -2.32 (-4514%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B5667.73%
----
----
EPS
-2.32054514.34%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf